CLINICAL RM ADVANCE. ACCELERATE. ACHIEVE. Trademark

Trademark Overview

On Friday, March 11, 2011, a trademark application was filed for CLINICAL RM ADVANCE. ACCELERATE. ACHIEVE. with the United States Patent and Trademark Office. The USPTO has given the CLINICAL RM ADVANCE. ACCELERATE. ACHIEVE. trademark a serial number of 85264478. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Wednesday, April 10, 2013. This trademark is owned by Clinical Research Management, Inc.. The CLINICAL RM ADVANCE. ACCELERATE. ACHIEVE. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials on behalf of medical, biopharmaceutical and biotechnology companies and government agencies to assist them with clinical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials on behalf of medical, biopharmaceutical and biotechnology companies and government agencies
clinical rm advance. accelerate. achieve.

General Information

Serial Number85264478
Word MarkCLINICAL RM ADVANCE. ACCELERATE. ACHIEVE.
Filing DateFriday, March 11, 2011
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateWednesday, April 10, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"CLINICAL"
Description of MarkThe mark consists of the stylized wording "CLINICAL RM" in blue and the stylized wording "ADVANCE. ACCELERATE. ACHIEVE." in green below, with a double helix consisting of circles in shades of green and blue bonds separating the words "CLINICAL" and "RM".
Goods and ServicesMedical and scientific research, namely, conducting clinical trials on behalf of medical, biopharmaceutical and biotechnology companies and government agencies to assist them with clinical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials on behalf of medical, biopharmaceutical and biotechnology companies and government agencies
Pseudo MarkCLINICAL RESEARCH MANAGEMENT ADVANCE. ACCELERATE. ACHIEVE.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 9, 2011
Primary Code042
First Use Anywhere DateSunday, May 1, 2011
First Use In Commerce DateSunday, May 1, 2011

Trademark Owner History

Party NameClinical Research Management, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHinckley, OH 44233

Trademark Events

Event DateEvent Description
Friday, April 12, 2013ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Wednesday, April 10, 2013ABANDONMENT - AFTER EX PARTE APPEAL
Wednesday, April 10, 2013EXPARTE APPEAL TERMINATED
Friday, January 25, 2013EX PARTE APPEAL-REFUSAL AFFIRMED
Thursday, June 28, 2012NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Thursday, June 28, 2012EXAMINERS STATEMENT E-MAILED
Thursday, June 28, 2012EXAMINERS STATEMENT - COMPLETED
Monday, April 30, 2012JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, February 28, 2012EX PARTE APPEAL-INSTITUTED
Tuesday, February 28, 2012EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, November 30, 2011NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Wednesday, November 30, 2011ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Wednesday, November 30, 2011ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Wednesday, November 9, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 9, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 9, 2011TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, September 30, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, September 30, 2011FINAL REFUSAL E-MAILED
Friday, September 30, 2011FINAL REFUSAL WRITTEN
Friday, September 9, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 9, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 7, 2011ASSIGNED TO LIE
Saturday, September 3, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 14, 2011NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, June 13, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 13, 2011NON-FINAL ACTION E-MAILED
Monday, June 13, 2011NON-FINAL ACTION WRITTEN
Monday, June 13, 2011USE AMENDMENT ACCEPTED
Sunday, June 12, 2011ASSIGNED TO EXAMINER
Wednesday, May 25, 2011AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, May 25, 2011USE AMENDMENT FILED
Tuesday, May 24, 2011TEAS AMENDMENT OF USE RECEIVED
Thursday, March 17, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, March 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 14, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

achieve accelerate advance clinical medical research companies government agencies biopharmaceutical biotechnology behalf trials